Switch To Branded denied as non-formulary by Humana?

Humana's specific coverage criteria for switch to branded are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied the Branded Drug as Non-Formulary — and How to Appeal

Humana's drug formularies are tiered lists of preferred medications. When a branded drug's generic equivalent is on the formulary and the branded version is not, Humana will deny a branded prescription as non-formulary — meaning your plan simply does not cover that specific product at any tier unless a medical exception is granted. This is one of the most common denial types and also one of the most commonly overturned on appeal when proper documentation is submitted.

## Why This Denial Is Appealable

Every Humana plan with a formulary must have a formulary exception process — a mechanism to cover a non-formulary drug when the patient has a medical reason the formulary alternatives are unsuitable. Federal law (ACA §2719) and CMS rules require this. The exception is not automatic, but it is available, and plans cannot deny it without reviewing the clinical evidence.

Your appeal rights: - Formulary exception request: This is often the first step — a separate, faster track than a standard appeal. Ask Humana for a formulary exception form; your prescriber must support it. - Internal appeal (ACA §2719 / ERISA §503): File within 180 days of the denial. Request a full-and-fair review of the clinical necessity for the branded version. - External review: Available after internal exhaustion. The IRO window is generally up to four months from final internal denial. - Expedited review (72 hours): Available when delay poses serious health risk.

## What to Gather

• Formulary exception letter from prescriber: Should document why the formulary alternative (generic) is inadequate — adverse reaction, therapeutic failure, or a specific clinical characteristic of the branded formulation required by your condition.
• Trial-and-failure documentation: Dates, outcomes, and any adverse events on the generic or other formulary alternatives you have tried.
• Diagnosis and clinical summary: Confirmation of the underlying condition and its severity, from chart notes and specialist records.
• Humana's formulary exception criteria: Request the current criteria document. Map your evidence to every requirement listed.

## Criteria-Mapping Structure

| Formulary Exception Requirement | Supporting Documentation | |---|---| | Medical diagnosis requiring this drug class | Diagnosis confirmation from prescriber/specialist | | Formulary alternative(s) tried and outcome | Dates, dose range, outcome, adverse events | | Clinical reason formulary alternative is unsuitable | Prescriber exception letter with objective chart support | | [Additional criteria] | Corresponding chart or lab documentation |

Your appeal letter (or exception request) should be precise: state which formulary alternative was tried, when, and what happened. The vaguer the documentation, the easier it is for Humana to uphold the denial. If the internal process fails, external review by an IRO applies objective clinical standards — not Humana's formulary tier structure.